Impact of engineered ACE2-Fc on SARS-CoV-2 infection
Researchers employ a structure-guided approach for the development of a series of ACE2-Fc variants using human IgG1 or IgG3 backbone.
Stay updated with breaking news from Ucleic Acid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers employ a structure-guided approach for the development of a series of ACE2-Fc variants using human IgG1 or IgG3 backbone.
This first-in-human study of golodirsen showed its long-term safety and biologic activity in patients with Duchenne Muscular Dystrophy (DMD). The approved exon-skipping therapy is designed to enable the production of functional dystrophin proteins, as described in the peer-reviewed journal Nucleic Acid Therapeutics.
Researchers use reference preparations from pooled swab samples to compare the analytical sensitivity of different SARS-CoV-2 assays
It would be hard to pick a single year out that made the creation of the Pfizer and Moderna vaccines possible, but the year 2005 would be in the discussion.
Scientists generate a VLP type NP platform made of recombinant viral antigens conjugated with TMV virions.